At TwelveStone Health Partners, we are deeply committed to standing with patients impacted by Alzheimer’s disease. This devastating condition affects nearly 7 million Americans, challenging not only memory and cognition but also emotional well-bring, independence and family dynamics. While a cure remains elusive, recent advancements are bringing hope—and TwelveStone is proud to be part of that progress.
One of the most promising breakthroughs in Alzheimer’s treatment is Leqembi (lecanemab-irmb), a groundbreaking infusion therapy designed to slow the progression of early-stage Alzheimer’s disease. As a trusted partner in specialty infusion care, TwelveStone is helping to deliver this innovative therapy to patients in a supportive, spa-like setting—empowering them to maintain their quality of life longer and more meaningfully.
What is Leqembi?
Leqembi is the first FDA-approved treatment shown to remove amyloid plaques from the brain and meaningfully delay cognitive decline in early Alzheimer’s. It represents a major advancement in the treatment of a disease that has historically offered few medical options. Administered via intravenous infusion every two weeks, Leqembi is intended for patients with mild cognitive impairment or mild dementia stage of the disease.
How TwelveStone Supports Patients on Leqembi
At TwelveStone, we’ve designed our infusion centers to meet more than just the medical needs of our patients. We support the emotional, spiritual and physical comfort of both patients and caregivers. From the moment a patient walks into one of our conveniently located infusion centers, they are welcomed into a calming environment supported by compassionate clinicians trained in Alzheimer’s care protocols and specialty therapies.
We work closely with neurologists and other referring providers to ensure continuity of care, proper monitoring, and ongoing communication throughout the treatment journey. Our team manages the logistics including prior authorizations, benefits verification, and infusion scheduling to ensure that families are free to focus on what matters most, spending quality time together.
A Message of Hope
While Alzheimer’s continues to pose enormous challenges, treatments like Leqembi are changing what had been a bleak narrative. Slowing disease progression can have a profound impact on a patient’s ability to engage in daily life, maintain connections, and preserve independence. It’s not just about extending time, but more importantly the quality of that time.
TwelveStone is honored to play a role in this evolving landscape. We believe that every patient deserves to be treated with dignity, every family member deserves support, and every breakthrough deserves to reach the people who need it most, right in their community.
If you or a loved one have been diagnosed with early-stage Alzheimer’s and may be a candidate for Leqembi, we invite you to connect with your healthcare provider or our team directly to learn how we can help.
Learn more at https://www.12stonehealth.com/chronic-conditions/alzheimers-disease/.
